🔎 Trials Near Me

Domov › Spinalna mišična atrofija › Illinois

Klinične študije za Spinalna mišična atrofija v Illinois

6 študij za Spinalna mišična atrofija išče udeležence na lokacijah v Illinois.

Mesta v Illinois

Uradno besedilo študije (angleško)

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

  • Ann and Robert H. Lurie Children Hospital of Chicago, Chicago
Vključevanje udeležencevFaza 4
3 Months – 24 Months · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05861986

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Vključevanje udeležencevFaza 2
Starost 5–17 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07287982

A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Vključevanje udeležencevFaza 1
Starost 3 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06555419

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

  • Lurie Childrens Hospital, Chicago
Vključevanje udeležencev
Starost 3 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05866419

A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

  • Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
Vključevanje udeležencevFaza 3
0 Days – 42 Days · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07221669

ALS/MND Natural History Study Data Repository

  • Northwestern University, Chicago
Vključevanje udeležencevOpazovalna študija
Starost 18–90 · Vsi spoli · Posodobljeno 20. maj 2026 · NCT05966038

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.